Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
10/05/20127:20AMMarketwiredBiotech Industry Applauds Introduction of the High Technology Small Business Research Incentives ActNASDAQ:IMGNImmunoGen Inc
10/02/201211:16AMZacksRoche Oncology Candidate Progresses - Analyst BlogNASDAQ:IMGNImmunoGen Inc
10/01/20127:00AMBusiness WireImmunoGen, Inc. Announces Overall Survival Data Reported for Trastuzumab Emtansine (T-DM1) Phase III EMILIA TrialNASDAQ:IMGNImmunoGen Inc
09/06/20127:45AMBusiness WireImmunoGen, Inc. Announces Presentation of New IMGN901 Clinical DataNASDAQ:IMGNImmunoGen Inc
09/04/20125:30AMBusiness WireImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor ConferencesNASDAQ:IMGNImmunoGen Inc
08/31/20124:09PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:IMGNImmunoGen Inc
08/30/20127:20AMMarketwiredBiotech Industry Merger and Acquisition Activity at a Four-Year HighNASDAQ:IMGNImmunoGen Inc
08/29/201212:53PMEdgar (US Regulatory)Annual Report (10-K)NASDAQ:IMGNImmunoGen Inc
08/27/201211:04AMZacksPositive Results on Roche Candidate - Analyst BlogNASDAQ:IMGNImmunoGen Inc
08/27/20128:07AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:IMGNImmunoGen Inc
08/27/20127:28AMDow Jones NewsImmunoGen Breast Cancer Drug Shows Positive Results; Shares UpNASDAQ:IMGNImmunoGen Inc
08/27/201212:00AMBusiness WireImmunoGen, Inc. Announces Trastuzumab Emtansine (T-DM1) Significantly Improved Survival in the EMILIA Phase III TrialNASDAQ:IMGNImmunoGen Inc
08/13/20127:20AMMarketwiredBiotechnology Industry Continues to Show Investors Strong Gains in 2012 -- Complete Genomics Soars on Strong ResultsNASDAQ:IMGNImmunoGen Inc
08/03/20125:41AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
08/03/20125:30AMBusiness WireImmunoGen, Inc. Reports Fourth Quarter & Fiscal Year 2012 Financial Results & Provides Corporate Update & Fiscal Year 2013 Gu...NASDAQ:IMGNImmunoGen Inc
08/01/20128:31AMPR Newswire (US)Critical Trade Alerts For Ford, Valero, Humana, Sourcefire, and ImmunoGen Released By InvestorsObserverNASDAQ:IMGNImmunoGen Inc
07/26/201212:20PMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss its Fourth Quarter and Fiscal Year 2012 Financial ResultsNASDAQ:IMGNImmunoGen Inc
07/23/20129:24AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/23/20129:24AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/23/20129:23AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/23/20129:22AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/23/20129:22AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/23/20129:21AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/23/20129:21AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/12/20124:20PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
07/12/20123:52PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:IMGNImmunoGen Inc
07/12/20128:10AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:IMGNImmunoGen Inc
07/12/20128:05AMBusiness WireImmunoGen, Inc. Prices Public Offering of Common StockNASDAQ:IMGNImmunoGen Inc
07/12/20125:00AMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:IMGNImmunoGen Inc
07/11/20123:01PMBusiness WireImmunoGen, Inc. Announces Proposed Public Offering of Common StockNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Your Recent History

Delayed Upgrade Clock